[1] He L,He XY,Lim LP,et al. A microRNA component of the p53 tumour suppressor network[J]. Nature,2007,447 (7148):1130–1134. [2] Tazawa H,Tsuchiya N,Izumiya M,et al. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in col human on cancer cells[J]. Proc Natl Acad Sci USA,2007,104 (39):15472–15477. [3] Corney DC,Flesken-Nikitin A,Godwin AK,et al. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth[J]. Cancer Res,2007, 67 (18):8433–8438. [4] Kumamoto K,Spillare EA,Fujita K,et al. Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate miR-34a,miR-34b,and miR-34c expression,and induce senescence[J]. Cancer Res,2008,68 (9):3193–3203. [5] Yamakuchi M,Ferlito M,Lowenstein CJ. MiR-34a repression of SIRT1 regulates apoptosis[J]. Proc Natl Acad Sci USA,2008,105 (36): 13421–13426. [6] Sun F,Fu HJ,Liu Q,et al. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest[J]. FEBS Lett,2008, 582 (10): 1564–1568. [7] Welch C,Chen Y,Stallings RL. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells[J]. Oncogene,2007,26 (34):5017–5022. [8] Jurong Yang,Dapeng Chen,Yani He,et al. MiR-34 modulates Caenorhabditis elegans lifespa via repressing the autophagy gene atg9[J]. AGE,2011. doi:10.1007/s11357-011-9324-3. [9] Nan Liu,Michael Landreh,Kajia Cao,et al. The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila[J]. LETTER, 2012,482 (7386):519–523. [10] Rokhlin OW,Scheinker VS,Taghiyev AF,et al. MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer[J]. Cancer Biol Ther,2008,7 (8):1288–1296. [11] Nora Bandi,Erik Vassella. MiR-34a and miR-15a/16 are co-regulated in nonsmall cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner[J]. Mol Cancer,2011, 10 (1): 55–65. [12] Lodygin D,Tarasov V,Epanchintsev A,et al. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer[J]. Cell Cycle,2008,7 (16):2591–2600. [13] Toyota M,Suzuki H,Sasaki Y,et al. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer[J]. Cancer Res,2008,68 (11): 4123–4132. [14] Ji Q,Hao X,Zhang M,et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells[J]. PLoS ONE,2009, 4 (8): e6816. [15] Hitoshi Yamazaki,Tsuyoshi Chijiwa,Yoshimasa Inoue,et al. Overexpression of the miR-34 family suppresses invasive growth of malignant melanoma with the wild-type p53 gene[J]. Exp Ther, 2012,3 (5):793–796. [16] Norimitsu Tanakaa,Shinichi Toyookaa,Junichi Soha,et al. Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung Cancer[J]. Lung Cancer,2012,76 (1):32–38. [17] Na Li,Hanjiang Fu,Yi Tie,et al. MiR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells[J]. Cancer Letters,2009,275 (1): 44–53. [18] Corney DC,Hwang CI,Matoso A,et al. Frequent downregulation of miR-34 family in human ovarian cancers[J]. Clin Cancer Res,2010,16 (4):1119–1128. [19] Soichiro Y,Sharanjot S,Shahana M,et al. MicroRNA- 34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma[J]. Carcinogenesis, 2011,2 (33):294–300. [20] 孙秀锦,黄铖铖,涂 彧,等. MiR-34在辐射损伤时对细胞周期的调控作用[J]. 苏州大学学报:医学版,2011,31(3): 350–353. [21] Kato M,Paranjape T,Ullrich R,et al. Mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells[J]. Oncogene,2009,28 (25):2419–2424. [22] 程 赢,和生辉,刘 聪,等. 辐射诱导性miR-34a 的表达对细胞辐射敏感性的影响[J]. 第二军医大学学报,2011,32 (4):368–371. [23] Cong Liu,Chuanfeng Zhou,Fu Gao,et al. MiR-34a in age and tissue related radio-sensitivity and serum miR-34a as a novel indicator of radiation injury[J]. Int J Biol Sci,2011,7 (2):221–233. [24] Lu J,Getz G,Miska EA,et al. MicroRNA expression profiles classify human cancers[J]. Nature, 2005,435 (7043):834–838. [25] Gallardo E,Navarro A,Vinolas N,et al. MiR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer[J]. Carcinogenesis,2009,30 (11):1903–1909. [26] Wiggins JF,Ruffino L,Kelnar K,et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34[J]. Cancer Res,2010,70 (14):5923–5930. |